Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis
- PMID: 29122918
- DOI: 10.1183/13993003.01552-2017
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis
Conflict of interest statement
Conflict of interest: None declared.
Comment in
-
Bedaquiline: how better to use it.Eur Respir J. 2017 Nov 9;50(5):1701670. doi: 10.1183/13993003.01670-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29122921 No abstract available.
Comment on
-
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.Eur Respir J. 2017 Jul 5;50(1):1700648. doi: 10.1183/13993003.00648-2017. Print 2017 Jul. Eur Respir J. 2017. PMID: 28679614 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources